Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The rising global incidence of breast cancer, driven by lifestyle changes and an aging population, is a key market driver.…
